No Data
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Takeda in Deal With Alloy Therapeutics to Develop Cell Therapy Platforms for Cancer
Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progress in Regenerative Medicine
Leerink Partners Maintains Century Therapeutics(IPSC.US) With Buy Rating
Promising Phase 1 Results for CNTY-101 in B-Cell Malignancies Boost Confidence in Century Therapeutics
Century Therapeutics, Inc. Demonstrates Strong Financial Management With No Senior Securities Defaults
No Data